Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial

Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)

(2016) Mikkel M. Schoos et al.   AMERICAN JOURNAL OF CARDIOLOGY

A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus

(2016) Rafael Romaguera et al.   JACC-Cardiovascular Interventions

Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents

(2016) Sebastian Kufner et al.   JACC-Cardiovascular Interventions

Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis

(2015) Pravesh Kumar Bundhun et al.   Cardiovascular Diabetology

Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment

(2015) Fumiyuki Otsuka et al.   EUROPEAN HEART JOURNAL

Effects of Probucol on Restenosis after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

(2015) Jichen Liu et al.   PLoS One

Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients

(2014) Eliano P. Navarese et al.   ATHEROSCLEROSIS

Assessment of Characteristics of Neointimal Hyperplasia after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus: An Optical Coherence Tomography Analysis

(2014) Feng Tian et al.   CARDIOLOGY

Pharmacological inhibition of coronary restenosis: systemic and local approaches

(2014) Elena Guerra et al.   EXPERT OPINION ON PHARMACOTHERAPY

Everolimus-Eluting Xience V/Promus Versus Zotarolimus-Eluting Resolute Stents in Patients With Diabetes Mellitus

(2014) Kyung Woo Park et al.   JACC-Cardiovascular Interventions

Five-year clinical follow-up of a randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial)

(2013) Thomas Stiermaier et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography

(2013) Salvatore Cassese et al.   HEART

In-Stent Neoatherosclerosis

(2012) Seung-Jung Park et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials

(2012) S. Bangalore et al.   BMJ-British Medical Journal

Polymer-Free Sirolimus- and Probucol-Eluting Versus New Generation Zotarolimus-Eluting Stents in Coronary Artery Disease

(2011) Steffen Massberg et al.   CIRCULATION

Current concepts on coronary revascularization in diabetic patients

(2011) M. Roffi et al.   EUROPEAN HEART JOURNAL

The Clinical Impact of Routine Angiographic Follow-Up in Randomized Trials of Drug-Eluting Stents

(2010) Takahiro Uchida et al.   JACC-Cardiovascular Interventions

A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents

(2009) R. A. Byrne et al.   EUROPEAN HEART JOURNAL

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

(2008) Theodore Mazzone et al.   LANCET